Unveiling 18 Analyst Insights On Legend Biotech
Legend Biotech (NASDAQ:LEGN) has been analyzed by 18 analysts in the last three months, revealing a diverse range…
A Glimpse Into The Expert Outlook On Halozyme Therapeutics Through 8 Analysts
8 analysts have shared their evaluations of Halozyme Therapeutics (NASDAQ:HALO) during the recent three months, expressing a mix…
Bath & Body Works Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Bath & Body Works, Inc. (NYSE:BBWI) is set to release first-quarter financial results, before the opening bell on…
Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going
In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024.
The report highlights a deceleration in market growth and notable shifts in sales dynamics among leading licensed producers (LPs).
Analyst Scoreboard: 18 Ratings For e.l.f. Beauty
Providing a diverse range of perspectives from bullish to bearish, 18 analysts have published ratings on e.l.f. Beauty…
Deep Dive Into Signet Jewelers Stock: Analyst Perspectives (9 Ratings)
During the last three months, 9 analysts shared their evaluations of Signet Jewelers (NYSE:SIG), revealing diverse outlooks from…
Beyond The Numbers: 7 Analysts Discuss Illumina Stock
Ratings for Illumina (NASDAQ:ILMN) were provided by 7 analysts in the past three months, showcasing a mix of…
Alcoa Set For Gains As China’s Aluminum Market Surplus Grows, Global Supply Tightens: JPMorgan
JPMorgan's Commodities Research team predicts turbulence in aluminum prices near term due to oversupply, but forecasts a rebound in the longer term.
Structure Therapeutics’ Obesity Candidate Is ‘ Very Competitive’ To Eli Lilly’s Orforglipron, Analyst Says
Structure Therapeutics reports positive 12-week Phase 2a obesity study results for GSBR-1290, showing a 6.2% weight loss. Cantor Fitzgerald maintains an Overweight rating with a $65 target
The Analyst Verdict: MongoDB In The Eyes Of 39 Experts
Providing a diverse range of perspectives from bullish to bearish, 39 analysts have published ratings on MongoDB (NASDAQ:MDB)…